SAN FRANCISCO — After 7 years, transcatheter aortic valve replacement (TAVR) remains equivalent to surgery with respect to durability and safety in low-risk patients, a finding that may blunt ...

Modern TAVR has challenged several misconceptions, offering a less invasive treatment option for aortic valve disease with ...

CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve replacement ...

WASHINGTON, D.C.—A randomized trial of patients with a narrowing of their heart’s aortic valve, but who had not yet begun to show the symptoms of cardiovascular disease, demonstrated that replacing ...

Of the two heart valve surgeries Janice Smith has had at OhioHealth Mansfield Hospital, the second was much easier for her. "I had a good experience both times," the 86-year-old said. "It's just that ...

At the American College of Cardiology (ACC) 2026 in New Orleans, retrospective results were presented demonstrating the possibility of using numerous pharmacotherapies, including sodium-glucose ...

TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial Since the approval of TAVR in low-risk surgical patients, there ...

Please provide your email address to receive an email when new articles are posted on . The RHEIA trial included enrolled-only women randomly assigned to transcatheter vs. surgical aortic valve ...

Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard ...

Aortic valve replacement is often necessary for people with aortic valve stenosis, a heart condition in which the aortic valve becomes narrowed or blocked, restricting the flow of blood (and the ...